Clinical Trials Logo

Filter by:
NCT ID: NCT03029104 Terminated - Keratoconus Clinical Trials

Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas

Start date: December 21, 2016
Phase: Phase 2
Study type: Interventional

This study will assess changes in visual acuity and corneal symmetry after corneal collagen cross-linking (CXL) of asymmetric corneas.

NCT ID: NCT03029000 Terminated - Clinical trials for Healthy Participants

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

GRANIX
Start date: August 2, 2017
Phase: Phase 3
Study type: Interventional

A multi-center, open-label, single-arm clinical study to assess effects of a 5-day regimen of 10 micrograms per kilogram (mcg/kg) of tbo-filgrastim administered subcutaneously daily on the mobilization of cluster of differentiation 34+ (CD34+) cells in at least 60 healthy male and female participants. The pharmacokinetics, pharmacodynamics, safety, tolerability, and immunogenicity of tbo-filgrastim will be assessed.

NCT ID: NCT03028805 Terminated - Clinical trials for Pulmonary Disease, Chronic Obstructive

Study of Automated Care Pathway for Patients With Chronic Obstructive Pulmonary Disease (COPD)

EPICPath
Start date: March 26, 2018
Phase: N/A
Study type: Interventional

This is a fully automated randomized trial with two randomization branch-points. The first is inclusion of disease-specific orders in the admission orders based on a predictive model using real-time data. The second is the use of dynamic orders that are end-user tested rather than static orders designed by a committee. The primary hypothesis is that automatic inclusion of disease specific orders with admission orders will improve adherence to guidelines for patients with COPD. The secondary hypothesis is that clinical and operational outcomes will improve, thereby improving value.

NCT ID: NCT03028740 Terminated - Clinical trials for Nonalcoholic Steatohepatitis

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

AURORA
Start date: April 5, 2017
Phase: Phase 3
Study type: Interventional

The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult participants with NASH.

NCT ID: NCT03028324 Terminated - Apraxia Speech Clinical Trials

Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)

Start date: August 9, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the influence of transcranial magnetic stimulation (TMS) on speech performance in individuals with primary progressive apraxia of speech.

NCT ID: NCT03028012 Terminated - Myofascial Pain Clinical Trials

TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone

Start date: May 2, 2017
Phase: Phase 4
Study type: Interventional

Hypothesis The main hypothesis of this study is that anti-inflammatory medications (ketorolac or dexamethasone) will provide longer-lasting and greater pain relief than just lidocaine in trigger point injections where a local twitch response is evoked at the time of the injection. Purpose/Specific Aims The primary objective of this study is to compare the efficacy of three substances used in TPIs with a LTR identified at the time of the injection: a CS (dexamethasone), a NSAID (ketorolac), or only a local anesthetic (lidocaine).

NCT ID: NCT03027700 Terminated - Hepatic Steatosis Clinical Trials

Methods to Detect Liver Fibrosis

Start date: January 26, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to learn more about liver fibrosis and methods to detect it. We will evaluate and compare multiple MRI based measures of liver fibrosis in subjects with and without liver disease.

NCT ID: NCT03026803 Terminated - Liver Cancer Clinical Trials

A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer

Start date: November 2006
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well giving oxaliplatin and capecitabine together works in treating patients with liver cancer.

NCT ID: NCT03026192 Terminated - Clinical trials for Patent Ductus Arteriosus

Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure

Start date: December 2016
Phase:
Study type: Observational

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

NCT ID: NCT03026166 Terminated - Clinical trials for Small Cell Lung Cancer

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

Start date: March 30, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of rovalpituzumab tesirine administered in combination with nivolumab or nivolumab and ipilimumab in participants with extensive-stage small cell lung cancer (SCLC).